Literature DB >> 27676339

A hepatitis B-free generation in China: from dream to reality.

Rong Fan1, Xueru Yin1, Zhihong Liu1, Zhihua Liu1, George Lau2, Jinlin Hou3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27676339     DOI: 10.1016/S1473-3099(16)30327-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  6 in total

Review 1.  Current advances in the elimination of hepatitis B in China by 2030.

Authors:  Shuye Zhang; Fusheng Wang; Zheng Zhang
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

2.  Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis.

Authors:  Zheng Hui; Shevanthi Nayagam; Polin Chan; Wang Fuzhen; Mark Thursz; Yin Zundong; Miao Ning; Sun Xiaojin; Fuqiang Cui; Zhang Guomin; Timothy B Hallett
Journal:  Bull World Health Organ       Date:  2020-10-28       Impact factor: 9.408

3.  Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil.

Authors:  Ashish Goyal; Ethan Obie Romero-Severson
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

4.  Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.

Authors:  Jianyong Zeng; Caixia Zheng; Hua Li
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01).

Authors:  Xueru Yin; Guorong Han; Hua Zhang; Mei Wang; Wenjun Zhang; Yunfei Gao; Mei Zhong; Xiaolan Wang; Xiaozhu Zhong; Guojun Shen; Chuangguo Yang; Huiyuan Liu; Zhihong Liu; Po-Lin Chan; Marc Bulterys; Fuqiang Cui; Hui Zhuang; Zhihua Liu; Jinlin Hou
Journal:  J Clin Transl Hepatol       Date:  2020-03-05

6.  Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study.

Authors:  Yang Zheng; Jie Wu; Cheng Ding; Kaijin Xu; Shigui Yang; Lanjuan Li
Journal:  Virol J       Date:  2020-08-28       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.